Lexology July 17, 2024
McCarter & English LLP

Through its recent decision in Loper Bright Enterprises v. Raimondo, No. 22-451 (S. Ct. June 28, 2024), the US Supreme Court overturned the landmark decision in Chevron U.S.A. Inc. v. Natural Resources Defense Council, Inc., 467 U.S. 837 (1984).

Impact on Healthcare Regulations

Federal agencies that oversee federal healthcare programs and have regulatory authority, such as the Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services, issue a significant number of regulations on an annual basis that impact healthcare. With the reversal of Chevron, it is likely that there will be an increase in challenges to regulations brought by entities, such as providers, that are impacted by these regulations. In addition, the reversal of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Regulations
'More scrutiny' in PE Stark law compliance & more expected regulatory trends
FDA, Health Canada give sneak peek into future AI regs
FDA strengthens AI regulation to ensure patient safety and innovation in healthcare
New Regulatory Innovation Office delivering new technologies faster
Salesforce's UK chief urges government not to regulate all AI companies in the same way

Share This Article